An Open-Label, Randomized, Multicenter Trial of Encorafenib + Binimetinib Evaluating a Standard-dose and a High-dose Regimen in Patients With BRAFV600-mutant Melanoma Brain Metastasis

Melanoma Institute Australia, North Sydney

Crows Nest Eye Surgery, Crows Nest

Royal north shore center hospital dermatology clinics, St Leonards

Mater Imaging, Wollstonecraft

UZ Antwerpen, Edegem

MD Anderson Cancer Center, Houston

Rocky Mountain Lions Eye Institute (RMLEI), Aurora

University of Colorado Denver CTO/CTRC - Outpatient., Aurora

University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora

University of Colorado Hospital - Anschutz Outpatient Pavilion, Aurora

University of Colorado Hospital, Aurora

Azienda Universitaria Policlinico Federico II, Napoli

S.C. Cardiologia, Napoli

S.C. Farmacia, Napoli

S.C. Medicina Nucleare e Terapia Metabolica, Napoli

SC Melanoma, Immunoterapia Oncologica e Terapie Innovative, Napoli

U.O. Radiodiagnostica 1, Napoli

The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate, Los Angeles

The Retina Partners, Santa Monica

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

OHSU Center for Health and Healing, Portland

Oregon Health & Science University Center for Health & Healing 2, Portland

Instituto Médico Especializado Alexander Fleming, Buenos Aires

Instituto de Oncologia de Rosario, Rosario

Fundacion CIDEA, CABA